Skip to content

The effect of pregabalin on postoperative pain in craniotomy

Evaluation of the pregabalin effect on postoperative pain in elective craniotomy

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160430027677N23
Enrollment
50
Registered
2022-10-05
Start date
2022-10-23
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post craniotomy pain. Acute pain

Interventions

Intervention 1: Intervention group: patients will receive Pregabalin 300 Mg oral tablet, 90 minutes before surgery. Intervention 2: Control group: patients will receive placebo oral tablet, 90 minutes

Sponsors

Oroumia University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Being at the age of 20 to 60 years old American Society of Anesthesiologists class I and II Being candidate for elective craniotomy

Exclusion criteria

Exclusion criteria: History of congenital mental retardation or mental disorders Pregnancy or breastfeeding History of systemic malignant tumor Previous treatment using this protocol or participation in another experimental study within the last 30 days Allergy to the drugs used in the study Body mass index greater than 30 Drug or alcohol addiction

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: In recovery, 6, 12 and 24 hours after surgery. Method of measurement: Visual Analogue Scale.

Secondary

MeasureTime frame
Mean Arterial Blood Pressure. Timepoint: In recovery, during Laryngoscopy, 6, 12 and 24 hours after surgery. Method of measurement: None Invasive Blood Pressure.;Mean pulse Rate. Timepoint: In recovery, during Laryngoscopy, 6, 12 and 24 hours after surgery. Method of measurement: Electrocardiogram.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahryar Sane

Oroumia University of Medical Sciences

sanesh@umsu.ac.ir+98 44 3223 4897

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026